We've found
2,839 High Blood Pressure (Hypertension)
clinical trials
We've found
2,839 High Blood Pressure (Hypertension)
clinical trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/13/2016
Prevention Trial to Achieve Cardiovascular Targets
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 8/28/2012
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
Status: Enrolling
Updated: 8/28/2012
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 10/23/2012
An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Status: Enrolling
Updated: 10/23/2012
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 10/23/2012
An Extension Study for Patients Who Participated in the CAMN107X2201 Study
Status: Enrolling
Updated: 10/23/2012
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 7/14/2016
Pharmacokinetics of Sildenafil in Premature Infants
Status: Enrolling,
Phase
I
Updated: 7/14/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 1/11/2013
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Reproductive Clinical Trial
Updated: 3/13/2013
Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
Status: Enrolling
Updated: 3/13/2013
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 10/29/2012
Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
Status: Enrolling,
Phase
II
Updated: 10/29/2012
Click here to add this to my saved trials

Pulmonary Hypertension Clinical Trial
Updated: 12/31/1969
Side Effects of Pulmonary Hypertension Medications
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Nephrology / Urology, Other Clinical Trial
Updated: 4/27/2015
Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)
Status: Enrolling,
Phase
I, II
Updated: 4/27/2015
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
Novel Screening Strategies for Scleroderma PAH
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 9/21/2015
Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
Status: Enrolling,
Phase
II
Updated: 9/21/2015
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/12/2013
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling,
Phase
III
Updated: 12/12/2013
Click here to add this to my saved trials

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Updated: 4/4/2016
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 12/31/1969
Resveratrol and Cardiovascular Health in the Elderly
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Mechanisms of Intradialytic Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension, Pulmonary Clinical Trial
Updated: 12/31/1969
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension, Pulmonary Clinical Trial
Updated: 12/31/1969
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension, Pulmonary Clinical Trial
Updated: 12/31/1969
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 11/28/2016
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 11/28/2016
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 11/28/2016
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 12/31/1969
Study 3: Minocycline Decreases Microglia Activation
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 12/31/1969
Diuretic Comparison Project
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Improving Chronic Disease Management With Pieces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Improving Chronic Disease Management With Pieces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Updated: 12/31/1969
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
